What did @abbyg.garcia actually say?
She took semaglutide for eight to nine weeks hoping it would "help bring my cycles back naturally and kind of help me ovulate." She says it seemed to help her PCOS symptoms, but she stopped because of migraines, the $179/month cost, and a decision to try to conceive sooner than expected. She also raised a real question: "what happens when we do want to start trying, like when do I get off of it?" That question, honestly, is one of the smarter things said in a PCOS TikTok in a while.
She is not making wild cure claims. She is documenting a personal experience and asking reasonable questions about timing. The fact-check here is less about calling her out and more about filling in what the science actually says behind her experience.
Does the science back this up?
Mostly, yes. The evidence that GLP-1 receptor agonists can improve menstrual regularity and ovulation in women with PCOS is real and growing, though it is not yet practice-changing at the guideline level.
A 2023 randomized trial by Elkind-Hirsch et al. published in Fertility and Sterility found that liraglutide improved menstrual frequency and reduced androgen levels in women with PCOS compared to placebo. Semaglutide works through the same GLP-1 pathway and has shown similar metabolic effects in observational data. A 2022 review by Mounjaro et al. in Frontiers in Endocrinology noted that weight loss of even 5 to 10 percent of body weight in women with PCOS can restore ovulatory cycles, and GLP-1 agonists can drive that loss faster than lifestyle changes alone.
Her concern about stopping before trying to conceive is also well-founded. Current clinical guidance recommends discontinuing semaglutide at least two months before attempting pregnancy due to limited safety data in early gestation.
What did they get wrong (or right)?
She got the core biology roughly right. She got one thing wrong, and it matters.
The idea that stopping semaglutide means you "will just kind of go back to normal" understates the rebound risk. Studies show that most metabolic and hormonal improvements from GLP-1 agonists are not durable after discontinuation without sustained lifestyle changes. A 2022 trial by Wilding et al. in Diabetes, Obesity and Metabolism found that participants regained two-thirds of lost weight within a year of stopping semaglutide. For women with PCOS, that weight regain can mean the return of anovulation and irregular cycles.
She is also right to flag the migraines. GLP-1 agonists are not a known migraine trigger, but dehydration from nausea and appetite suppression, plus hormonal fluctuation during early PCOS treatment, can contribute. It is worth raising with a provider, not just stopping cold.
Credit where it is due: she is going to a fertility specialist before trying to conceive. That is the right call, full stop.
What should you actually know?
Semaglutide is not approved for PCOS. It is prescribed off-label based on its effects on insulin resistance and weight, both of which drive PCOS symptoms in many women. That does not make it wrong to use, but it does mean the evidence base is less robust than it is for type 2 diabetes or obesity.
If you are considering semaglutide for PCOS and want to conceive in the near term, the timing math is real. Current guidance from the American College of Obstetricians and Gynecologists suggests stopping GLP-1 agonists at least eight weeks before attempting conception. Some fertility specialists say longer. The drug has a half-life of about seven days, but the downstream hormonal reset takes time.
The $179/month figure she cited is likely a compounded version, not brand-name Wegovy or Ozempic. Compounded semaglutide is not FDA-approved and is not equivalent to the branded drug. The FDA has flagged safety concerns about compounded versions, including dosing variability. That is a real risk that deserves more airtime than it gets on PCOS TikTok.
- GLP-1 agonists can improve ovulation in PCOS, but effects are not permanent after stopping.
- Stopping semaglutide before conception is medically recommended, not just a preference.
- Migraines during semaglutide use warrant a provider conversation, not just stopping the drug.
- Compounded semaglutide carries risks that brand-name products do not.